Overview
Since the inaugural meeting in 1970, the Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management and treatment of patients with headache.
Education is presented in didactic, case-based, evidence-based, panel and demonstrative formats over the course of four days. The Symposium is designed for general practitioners, internists, pediatricians, neurologists, anesthesiologists, dentists, physical therapists, psychologists, psychiatrists, nurse practitioners, physician assistants, nurses, and other health professionals who treat headache.
Helpful Links for Attendees:
On Demand Recordings and Evaluation
Registration
Registration is now open for the On Demand Program! View registration rates and updates here.
FAQ
Review frequently asked questions about the Symposium or download a copy here.
Shop AHS
Stock up on limited edition Scottsdale Headache Symposium®-branded products before time runs out! Order your gear on our virtual store, Shop AHS, here.
AHS-branded products are now available for purchase year-round and 15% of the proceeds will be dedicated to supporting AHS research, advocacy, and education initiatives. Shop AHS and you will be actively contributing to the advancement of our mission to improve the lives of individuals living with migraine and other headache disorders.
Health and Safety Policy
The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.
Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.
Special Note for People with Disabilities
The American Headache Society® wishes to take steps to ensure that no individual with a disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Headquarters at 856-423-0043, write to us at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.
Scottsdale Program Committee
Co-Chairs
Deborah I. Friedman, MD, MPH, FAHS
Key Whitman Eye Center
Dallas, TX
Rashmi B. Halker Singh, MD, FAHS
Mayo Clinic
Scottsdale, AZ
Scott W. Powers, PhD, FAHS
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Committee Members
Simon Akerman, PhD
University of Maryland, Baltimore
Baltimore, MD
Stephanie J. Nahas, MD, MSEd, FAHS
Thomas Jefferson University
Philadelphia, PA
Meredith Barad, MD
Stanford Pain Management
Redwood City, CA
Ana Recober, MD
Main Line Health Care
Philadelphia, PA
Carrie Dougherty, MD, FAHS
MedStar Georgetown Headache Center
Washington, DC
Adam Sprouse Blum, MD
University of Vermont
Burlington, VT
Shivang Joshi, MD, MPH, Rph, FAHS
Community Neuroscience Services
Westborough, MA
Raissa Villanueva, MD, MPH
University of Rochester Medical Center
Rochester, NY